Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

British Journal of Cancer
A MitraR Eeles

Abstract

There is a high and rising prevalence of prostate cancer (PRCA) within the male population of the United Kingdom. Although the relative risk of PRCA is higher in male BRCA2 and BRCA1 mutation carriers, the histological characteristics of this malignancy in these groups have not been clearly defined. We present the histopathological findings in the first UK series of BRCA1 and BRCA2 mutation carriers with PRCA. The archived histopathological tissue sections of 20 BRCA1/2 mutation carriers with PRCA were collected from histopathology laboratories in England, Ireland and Scotland. The cases were matched to a control group by age, stage and serum PSA level of PRCA cases diagnosed in the general population. Following histopathological evaluation and re-grading according to current conventional criteria, Gleason scores of PRCA developed by BRCA1/2 mutation carriers were identified to be significantly higher (Gleason scores 8, 9 or 10, P=0.012) than those in the control group. Since BRCA1/2 mutation carrier status is associated with more aggressive disease, it is a prognostic factor for PRCA outcome. Targeting screening to this population may detect disease at an earlier clinical stage which may therefore be beneficial.

References

Aug 1, 1994·The American Journal of Surgical Pathology·D G Bostwick
May 15, 1997·The New England Journal of Medicine·J P StruewingM A Tucker
Dec 31, 1997·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·S SigurdssonE Jonsson
Aug 5, 1999·Journal of the National Cancer Institute·UNKNOWN Breast Cancer Linkage Consortium
Sep 19, 2002·Journal of the National Cancer Institute·Deborah ThompsonUNKNOWN Breast Cancer Linkage Consortium
Dec 11, 2002·American Journal of Human Genetics·Stephen M EdwardsUNKNOWN British Association of Urological Surgeons Section of Oncology
May 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Christopher R KingJoseph C Presti
Aug 13, 2005·The American Journal of Surgical Pathology·Jonathan I EpsteinUNKNOWN ISUP Grading Committee
Jul 22, 2006·International Journal of Cancer. Journal International Du Cancer·Gerrit DraismaHarry J de Koning
Jun 15, 2007·Journal of the National Cancer Institute·Laufey TryggvadóttirHrafn Tulinius
Sep 21, 2007·Histopathology·D M BerneyUNKNOWN Trans-Atlantic prostate group
Nov 6, 2007·BJU International·Daniel M BerneyUNKNOWN Trans-Atlantic Prostate Group

❮ Previous
Next ❯

Citations

Nov 26, 2013·Biomarkers in Medicine·Sophie E McGrathHardev Pandha
Aug 8, 2014·British Journal of Cancer·M R AkbariR K Nam
Aug 19, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Elaine A Ostrander, Miriam S Udler
Mar 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David J GallagherKenneth Offit
Apr 15, 2010·Cancer Research·Michelangelo FiorentinoLorelei Mucci
Sep 2, 2010·PloS One·Regina Berretta, Pablo Moscato
Apr 8, 2011·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Danny VespriniRobert G Bristow
May 24, 2011·Familial Cancer·Nina StrømsvikEva Gjengedal
Jan 16, 2013·Nature Reviews. Urology·Nassim TaherianWilliam D Foulkes
Dec 4, 2013·Nature Reviews. Urology·Rosalind EelesZsofia Kote-Jarai
Feb 15, 2012·Expert Opinion on Investigational Drugs·Xiaojun LiuWilliam Plunkett
Aug 28, 2014·Journal of Medicinal Food·Mohamed M RafiJohn J Bright
Nov 14, 2014·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Heather HampelUNKNOWN Guideline Development Group, American College of Medical Genetics and Genomics Professional Practice and Guidelines Committe
Apr 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elena CastroRosalind Eeles
Apr 12, 2017·Seminars in Oncology·Rosalyn W StewartYoungjee Choi
Jul 8, 2011·The Cochrane Database of Systematic Reviews·Frank PeinemannStefan Sauerland
Jun 26, 2008·British Journal of Cancer·S A NarodChristina Bellati
Nov 11, 2014·Journal of Surgical Oncology·Thereasa A RichBanu Arun
Dec 8, 2015·International Journal of Cancer. Journal International Du Cancer·Henry T LynchIsaac Powell
Nov 5, 2017·Cold Spring Harbor Perspectives in Medicine·Alexander DiasRos Eeles
Sep 18, 2009·The Journal of Urology·Robert A Gardiner
Feb 13, 2018·BMC Cancer·Mohammed IbrahimDana Zakalik
Dec 17, 2009·Histopathology·Anita MitraChristopher S Foster
Jun 1, 2013·British Journal of Cancer·C CybulskiUNKNOWN Polish Hereditary Prostate Cancer Consortium
Apr 24, 2012·Asian Journal of Andrology·Elena Castro, Rosalind Eeles
May 16, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·James L MohlerDeborah A Freedman-Cass
Apr 4, 2015·Journal of Clinical Pathology·S HusseinT Van der Kwast
Sep 11, 2019·Advances in Anatomic Pathology·Farzana A Faisal, Tamara L Lotan
Sep 17, 2013·International Journal of Cancer. Journal International Du Cancer·Aniruddh KashyapUNKNOWN Polish Hereditary Prostate Cancer Consortium
Feb 22, 2011·Journal of Surgical Oncology·David M Euhus
Jan 29, 2013·Current Osteoporosis Reports·Stephen P TuckHarish K Datta
May 23, 2019·Current Opinion in Urology·Stephen T RyanA Karim Kader
Aug 8, 2020·Expert Review of Anticancer Therapy·Marco StellatoGiuseppe Procopio

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Software Mentioned

IMPACT

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.